October 29, 2008
- Sale Reinforces Strategic Focus and Enhances Cash Position - HOPKINTON, Mass., Oct. 29 -- Caliper Life Sciences, Inc. (Nasdaq: CALP - News), a leading provider of tools and services for drug discovery and life sciences research, today announced that it has reached an agreement to sell its Pharmaceutical Development & Quality Analysis (PDQ) product [...]
Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
October 29, 2008
The Fondation du Centre hospitalier universitaire de Sherbrooke (CHUS) is proud to announce that Waters Corporation has donated a Waters® Synapt(TM) MS System, the latest generation of mass spectrometers. This gift -- worth a total C$1.1 million -- is the result of a partnership between Waters and CHUS which is critical to the creation of [...]
October 29, 2008
Tripos’ Widely Installed Discovery Research Software, SYBYL, is Now Available to an Even Broader Spectrum of Molecular Modeling Scientists Globally ST. LOUIS--Tripos International, leading provider of drug discovery informatics products and services, today announced the release of its popular SYBYL software for Mac OS X Leopard. SYBYL, a suite of computational chemistry and molecular modeling [...]
Q Chip Introduces ReaXT PCR Assays For Effortless Detection of Hospital Acquired Infections
October 29, 2008
ReaX™ PCR Assays For Effortless Detection of Hospital Acquired Infections Picture available on request from [email protected] Cardiff, UK, 29 October 2008 – Q Chip Ltd, a leading developer of microencapsulation solutions, has expanded its ReaX™ range of enhanced PCR products by the introduction of ReaX beads for the detection of bacterial and viral hospital acquired [...]
Spartan Bioscience Announces New Agreement With NorDiag ASA
October 29, 2008
Spartan Bioscience Inc, a Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications, and NorDiag ASA, a Norwegian biotechnology company that develops, manufacturers and markets automated nucleic acid sample preparation instruments and magnetic bead based reagents for assays that require the purification of nucleic acid from difficult clinical samples such [...]
October 29, 2008
Advanced technology MobileTrace and Itemiser used to detect drugs entering night clubs, helping ensure a safer environment for patrons BRADENTON, Fla.--GE Security, Inc., a business of GE Enterprise Solutions (NYSE: GE - News), today announced MobileTrace, a handheld trace detection instrument capable of simultaneous narcotics and explosives detection, is playing a critical role in helping [...]
October 29, 2008
Santa Barbara, CA, Oct. 29, 2008 – Asylum Research, the technology leader in Atomic Force/Scanning Probe Microscopy (AFM/SPM), announced today that it is introducing the Cypher AFM, the industry’s first completely new small sample AFM/SPM in over a decade. Cypher is the world’s highest resolution AFM, providing more capability, more control, and more modularity with [...]
October 29, 2008
Researchers from the Ghent University Hospital in Belgium and Applied Biosystems Inc. (NYSE:ABI) have published a study demonstrating the effectiveness of a new method for profiling microRNAs in small samples. The study, entitled "High-throughput stem-loop RT-PCR miRNA expression profiling using minute amounts of input RNA," describes the simultaneous profiling of 450 human microRNAs from samples [...]
Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research
October 29, 2008
ST. LOUIS, Oct. 30 -- Sigma-Aldrich (Nasdaq: SIAL) today introduced its Imprint(TM) Methylated DNA Quantification Kit (MDQ1) for epigenetic research http://www.sigma-aldrich.com/mdq1. The Methylated DNA Quantification Kit employs a familiar ELISA-like procedure, with no radioactivity or chromatography, to measure global methylation in less than four hours. The kits are effective with a DNA input as low [...]
Avantium Completes EUR 18 Million Financing Round
October 29, 2008
AMSTERDAM, October 29 -- Avantium announced today the successful completion of a EUR 18 million private financing round. Avantium is active in the development and commercialization of Furanics, Avantium's next generation biofuel and bioplastic, and the improvement of pharmaceutical products. The financing will be used to accelerate its two proprietary development programs. The focus of [...]
